nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—DRD1—obesity	0.156	0.444	CbGaD
Zuclopenthixol—DRD2—obesity	0.11	0.313	CbGaD
Zuclopenthixol—HTR2A—obesity	0.0849	0.242	CbGaD
Zuclopenthixol—DRD1—Phenylpropanolamine—obesity	0.0705	0.172	CbGbCtD
Zuclopenthixol—ADRA1A—Phendimetrazine—obesity	0.0617	0.15	CbGbCtD
Zuclopenthixol—ADRA2A—Benzphetamine—obesity	0.0488	0.119	CbGbCtD
Zuclopenthixol—ADRA1A—Benzphetamine—obesity	0.0467	0.114	CbGbCtD
Zuclopenthixol—ADRA2A—Phenylpropanolamine—obesity	0.0465	0.113	CbGbCtD
Zuclopenthixol—ADRA1A—Phenylpropanolamine—obesity	0.0446	0.109	CbGbCtD
Zuclopenthixol—ADRA2A—Methamphetamine—obesity	0.039	0.0949	CbGbCtD
Zuclopenthixol—CYP2D6—Phentermine—obesity	0.0162	0.0395	CbGbCtD
Zuclopenthixol—CYP2D6—Bupropion—obesity	0.0138	0.0336	CbGbCtD
Zuclopenthixol—CYP2D6—Methamphetamine—obesity	0.013	0.0316	CbGbCtD
Zuclopenthixol—CYP2D6—Cimetidine—obesity	0.0101	0.0246	CbGbCtD
Zuclopenthixol—HTR2A—sympathetic nervous system—obesity	0.00148	0.121	CbGeAlD
Zuclopenthixol—HTR2A—vagus nerve—obesity	0.00143	0.117	CbGeAlD
Zuclopenthixol—HTR2A—autonomic nervous system—obesity	0.000994	0.0815	CbGeAlD
Zuclopenthixol—ADRA1A—hindbrain—obesity	0.000648	0.0531	CbGeAlD
Zuclopenthixol—DRD2—hindbrain—obesity	0.000635	0.0521	CbGeAlD
Zuclopenthixol—DRD5—endocrine gland—obesity	0.000451	0.037	CbGeAlD
Zuclopenthixol—HTR2A—hindbrain—obesity	0.000419	0.0343	CbGeAlD
Zuclopenthixol—DRD2—respiratory system—obesity	0.000388	0.0318	CbGeAlD
Zuclopenthixol—CYP2D6—hindbrain—obesity	0.000381	0.0313	CbGeAlD
Zuclopenthixol—ADRA2A—islet of Langerhans—obesity	0.000318	0.0261	CbGeAlD
Zuclopenthixol—HRH1—respiratory system—obesity	0.000306	0.0251	CbGeAlD
Zuclopenthixol—ADRA1A—cardiovascular system—obesity	0.000303	0.0248	CbGeAlD
Zuclopenthixol—ADRA1A—adipose tissue—obesity	0.000267	0.0219	CbGeAlD
Zuclopenthixol—DRD2—pituitary gland—obesity	0.000263	0.0216	CbGeAlD
Zuclopenthixol—HTR2A—respiratory system—obesity	0.000256	0.021	CbGeAlD
Zuclopenthixol—ADRA1A—adrenal gland—obesity	0.00024	0.0196	CbGeAlD
Zuclopenthixol—ADRA1A—endocrine gland—obesity	0.000208	0.017	CbGeAlD
Zuclopenthixol—HRH1—adipose tissue—obesity	0.000207	0.017	CbGeAlD
Zuclopenthixol—ADRA2A—pituitary gland—obesity	0.000204	0.0167	CbGeAlD
Zuclopenthixol—DRD2—endocrine gland—obesity	0.000204	0.0167	CbGeAlD
Zuclopenthixol—ADRA2A—adipose tissue—obesity	0.000203	0.0167	CbGeAlD
Zuclopenthixol—HTR2A—cardiovascular system—obesity	0.000196	0.0161	CbGeAlD
Zuclopenthixol—HRH1—digestive system—obesity	0.000195	0.016	CbGeAlD
Zuclopenthixol—ADRA1A—liver—obesity	0.000187	0.0154	CbGeAlD
Zuclopenthixol—HRH1—adrenal gland—obesity	0.000185	0.0152	CbGeAlD
Zuclopenthixol—ADRA2A—adrenal gland—obesity	0.000182	0.0149	CbGeAlD
Zuclopenthixol—HTR2A—pituitary gland—obesity	0.000173	0.0142	CbGeAlD
Zuclopenthixol—HTR2A—digestive system—obesity	0.000163	0.0133	CbGeAlD
Zuclopenthixol—HRH1—endocrine gland—obesity	0.000161	0.0132	CbGeAlD
Zuclopenthixol—ADRA2A—endocrine gland—obesity	0.000158	0.013	CbGeAlD
Zuclopenthixol—HTR2A—adrenal gland—obesity	0.000155	0.0127	CbGeAlD
Zuclopenthixol—CYP2D6—digestive system—obesity	0.000148	0.0121	CbGeAlD
Zuclopenthixol—Hot flush—Topiramate—obesity	0.000141	0.00113	CcSEcCtD
Zuclopenthixol—Flatulence—Sibutramine—obesity	0.000141	0.00112	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Bupropion—obesity	0.000141	0.00112	CcSEcCtD
Zuclopenthixol—Urethral disorder—Bupropion—obesity	0.00014	0.00112	CcSEcCtD
Zuclopenthixol—Amnesia—Topiramate—obesity	0.00014	0.00112	CcSEcCtD
Zuclopenthixol—Increased appetite—Topiramate—obesity	0.00014	0.00112	CcSEcCtD
Zuclopenthixol—Tension—Sibutramine—obesity	0.00014	0.00112	CcSEcCtD
Zuclopenthixol—Menopausal symptoms—Topiramate—obesity	0.00014	0.00112	CcSEcCtD
Zuclopenthixol—Vision blurred—Orlistat—obesity	0.000139	0.00111	CcSEcCtD
Zuclopenthixol—Nervousness—Sibutramine—obesity	0.000139	0.00111	CcSEcCtD
Zuclopenthixol—Vomiting—Cimetidine—obesity	0.000139	0.00111	CcSEcCtD
Zuclopenthixol—Thirst—Topiramate—obesity	0.000139	0.00111	CcSEcCtD
Zuclopenthixol—Visual impairment—Bupropion—obesity	0.000138	0.0011	CcSEcCtD
Zuclopenthixol—Rash—Cimetidine—obesity	0.000138	0.0011	CcSEcCtD
Zuclopenthixol—Dermatitis—Cimetidine—obesity	0.000138	0.0011	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Orlistat—obesity	0.000137	0.00109	CcSEcCtD
Zuclopenthixol—Flupentixol—DRD1—obesity	0.000137	0.0324	CrCbGaD
Zuclopenthixol—Headache—Cimetidine—obesity	0.000137	0.00109	CcSEcCtD
Zuclopenthixol—Purpura—Topiramate—obesity	0.000137	0.00109	CcSEcCtD
Zuclopenthixol—Nausea—Diethylpropion—obesity	0.000136	0.00109	CcSEcCtD
Zuclopenthixol—Vision blurred—Sibutramine—obesity	0.000135	0.00108	CcSEcCtD
Zuclopenthixol—HTR2A—endocrine gland—obesity	0.000134	0.011	CbGeAlD
Zuclopenthixol—Tremor—Sibutramine—obesity	0.000134	0.00107	CcSEcCtD
Zuclopenthixol—Eye disorder—Bupropion—obesity	0.000134	0.00107	CcSEcCtD
Zuclopenthixol—Tinnitus—Bupropion—obesity	0.000134	0.00107	CcSEcCtD
Zuclopenthixol—Malaise—Orlistat—obesity	0.000133	0.00106	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Bupropion—obesity	0.000133	0.00106	CcSEcCtD
Zuclopenthixol—Vertigo—Orlistat—obesity	0.000133	0.00106	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Sibutramine—obesity	0.000133	0.00106	CcSEcCtD
Zuclopenthixol—Agitation—Sibutramine—obesity	0.000131	0.00105	CcSEcCtD
Zuclopenthixol—Disturbance in sexual arousal—Topiramate—obesity	0.000131	0.00104	CcSEcCtD
Zuclopenthixol—Palpitations—Orlistat—obesity	0.000131	0.00104	CcSEcCtD
Zuclopenthixol—Angiopathy—Bupropion—obesity	0.00013	0.00104	CcSEcCtD
Zuclopenthixol—Migraine—Topiramate—obesity	0.00013	0.00104	CcSEcCtD
Zuclopenthixol—Nausea—Cimetidine—obesity	0.00013	0.00104	CcSEcCtD
Zuclopenthixol—Immune system disorder—Bupropion—obesity	0.000129	0.00103	CcSEcCtD
Zuclopenthixol—Malaise—Sibutramine—obesity	0.000129	0.00103	CcSEcCtD
Zuclopenthixol—Vertigo—Sibutramine—obesity	0.000128	0.00103	CcSEcCtD
Zuclopenthixol—Syncope—Sibutramine—obesity	0.000128	0.00102	CcSEcCtD
Zuclopenthixol—Convulsion—Orlistat—obesity	0.000128	0.00102	CcSEcCtD
Zuclopenthixol—Leukopenia—Sibutramine—obesity	0.000128	0.00102	CcSEcCtD
Zuclopenthixol—Arrhythmia—Bupropion—obesity	0.000128	0.00102	CcSEcCtD
Zuclopenthixol—Palpitations—Sibutramine—obesity	0.000126	0.00101	CcSEcCtD
Zuclopenthixol—Myalgia—Orlistat—obesity	0.000126	0.001	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Sibutramine—obesity	0.000126	0.001	CcSEcCtD
Zuclopenthixol—Mental disorder—Bupropion—obesity	0.000125	0.001	CcSEcCtD
Zuclopenthixol—Urinary retention—Topiramate—obesity	0.000125	0.001	CcSEcCtD
Zuclopenthixol—Anxiety—Orlistat—obesity	0.000125	0.001	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000125	0.000997	CcSEcCtD
Zuclopenthixol—Malnutrition—Bupropion—obesity	0.000125	0.000995	CcSEcCtD
Zuclopenthixol—Discomfort—Orlistat—obesity	0.000124	0.000992	CcSEcCtD
Zuclopenthixol—Ataxia—Topiramate—obesity	0.000124	0.00099	CcSEcCtD
Zuclopenthixol—Convulsion—Sibutramine—obesity	0.000124	0.000989	CcSEcCtD
Zuclopenthixol—Hypertension—Sibutramine—obesity	0.000123	0.000985	CcSEcCtD
Zuclopenthixol—Dry mouth—Orlistat—obesity	0.000123	0.000982	CcSEcCtD
Zuclopenthixol—Flatulence—Bupropion—obesity	0.000123	0.00098	CcSEcCtD
Zuclopenthixol—CYP2D6—endocrine gland—obesity	0.000122	0.01	CbGeAlD
Zuclopenthixol—Tension—Bupropion—obesity	0.000122	0.000976	CcSEcCtD
Zuclopenthixol—Liver function test abnormal—Topiramate—obesity	0.000122	0.000972	CcSEcCtD
Zuclopenthixol—Myalgia—Sibutramine—obesity	0.000122	0.000972	CcSEcCtD
Zuclopenthixol—Acetophenazine—DRD1—obesity	0.000122	0.0288	CrCbGaD
Zuclopenthixol—Anxiety—Sibutramine—obesity	0.000121	0.000968	CcSEcCtD
Zuclopenthixol—HTR2A—liver—obesity	0.000121	0.00993	CbGeAlD
Zuclopenthixol—Nervousness—Bupropion—obesity	0.000121	0.000966	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Orlistat—obesity	0.000121	0.000962	CcSEcCtD
Zuclopenthixol—Discomfort—Sibutramine—obesity	0.00012	0.00096	CcSEcCtD
Zuclopenthixol—Breast disorder—Topiramate—obesity	0.000119	0.000951	CcSEcCtD
Zuclopenthixol—Dry mouth—Sibutramine—obesity	0.000119	0.00095	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Orlistat—obesity	0.000118	0.000944	CcSEcCtD
Zuclopenthixol—Nasopharyngitis—Topiramate—obesity	0.000118	0.000941	CcSEcCtD
Zuclopenthixol—Vision blurred—Bupropion—obesity	0.000117	0.000938	CcSEcCtD
Zuclopenthixol—Skin disorder—Orlistat—obesity	0.000117	0.000935	CcSEcCtD
Zuclopenthixol—Tremor—Bupropion—obesity	0.000117	0.000932	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Sibutramine—obesity	0.000117	0.000931	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Orlistat—obesity	0.000117	0.00093	CcSEcCtD
Zuclopenthixol—Alanine aminotransferase increased—Topiramate—obesity	0.000116	0.000928	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Bupropion—obesity	0.000116	0.000923	CcSEcCtD
Zuclopenthixol—Shock—Sibutramine—obesity	0.000115	0.000916	CcSEcCtD
Zuclopenthixol—Agitation—Bupropion—obesity	0.000115	0.000914	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Sibutramine—obesity	0.000114	0.000912	CcSEcCtD
Zuclopenthixol—Tachycardia—Sibutramine—obesity	0.000114	0.000909	CcSEcCtD
Zuclopenthixol—Skin disorder—Sibutramine—obesity	0.000113	0.000905	CcSEcCtD
Zuclopenthixol—Eosinophilia—Topiramate—obesity	0.000113	0.000901	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Sibutramine—obesity	0.000113	0.0009	CcSEcCtD
Zuclopenthixol—Malaise—Bupropion—obesity	0.000112	0.000897	CcSEcCtD
Zuclopenthixol—Vertigo—Bupropion—obesity	0.000112	0.000894	CcSEcCtD
Zuclopenthixol—Syncope—Bupropion—obesity	0.000112	0.000892	CcSEcCtD
Zuclopenthixol—Leukopenia—Bupropion—obesity	0.000112	0.000891	CcSEcCtD
Zuclopenthixol—Anorexia—Sibutramine—obesity	0.000111	0.000888	CcSEcCtD
Zuclopenthixol—Sweating increased—Topiramate—obesity	0.000111	0.000886	CcSEcCtD
Zuclopenthixol—CYP2D6—liver—obesity	0.00011	0.00905	CbGeAlD
Zuclopenthixol—Palpitations—Bupropion—obesity	0.00011	0.000879	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Orlistat—obesity	0.00011	0.000877	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Bupropion—obesity	0.00011	0.000874	CcSEcCtD
Zuclopenthixol—Insomnia—Orlistat—obesity	0.000109	0.00087	CcSEcCtD
Zuclopenthixol—Hypotension—Sibutramine—obesity	0.000109	0.00087	CcSEcCtD
Zuclopenthixol—Paraesthesia—Orlistat—obesity	0.000108	0.000864	CcSEcCtD
Zuclopenthixol—Pancytopenia—Topiramate—obesity	0.000108	0.000864	CcSEcCtD
Zuclopenthixol—Convulsion—Bupropion—obesity	0.000108	0.000862	CcSEcCtD
Zuclopenthixol—Hypertension—Bupropion—obesity	0.000108	0.000859	CcSEcCtD
Zuclopenthixol—Propericiazine—DRD1—obesity	0.000107	0.0254	CrCbGaD
Zuclopenthixol—Dysuria—Topiramate—obesity	0.000107	0.000851	CcSEcCtD
Zuclopenthixol—Neutropenia—Topiramate—obesity	0.000107	0.000851	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Sibutramine—obesity	0.000106	0.000849	CcSEcCtD
Zuclopenthixol—Dyspepsia—Orlistat—obesity	0.000106	0.000847	CcSEcCtD
Zuclopenthixol—Myalgia—Bupropion—obesity	0.000106	0.000847	CcSEcCtD
Zuclopenthixol—Anxiety—Bupropion—obesity	0.000106	0.000844	CcSEcCtD
Zuclopenthixol—Insomnia—Sibutramine—obesity	0.000106	0.000842	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000105	0.000841	CcSEcCtD
Zuclopenthixol—Erectile dysfunction—Topiramate—obesity	0.000105	0.000838	CcSEcCtD
Zuclopenthixol—Discomfort—Bupropion—obesity	0.000105	0.000837	CcSEcCtD
Zuclopenthixol—Decreased appetite—Orlistat—obesity	0.000105	0.000837	CcSEcCtD
Zuclopenthixol—Paraesthesia—Sibutramine—obesity	0.000105	0.000836	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Orlistat—obesity	0.000104	0.000831	CcSEcCtD
Zuclopenthixol—Dyspnoea—Sibutramine—obesity	0.000104	0.00083	CcSEcCtD
Zuclopenthixol—Photosensitivity reaction—Topiramate—obesity	0.000104	0.00083	CcSEcCtD
Zuclopenthixol—Fatigue—Orlistat—obesity	0.000104	0.00083	CcSEcCtD
Zuclopenthixol—Dry mouth—Bupropion—obesity	0.000104	0.000828	CcSEcCtD
Zuclopenthixol—Somnolence—Sibutramine—obesity	0.000104	0.000828	CcSEcCtD
Zuclopenthixol—Weight increased—Topiramate—obesity	0.000104	0.000828	CcSEcCtD
Zuclopenthixol—Weight decreased—Topiramate—obesity	0.000103	0.000823	CcSEcCtD
Zuclopenthixol—Pain—Orlistat—obesity	0.000103	0.000823	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Topiramate—obesity	0.000103	0.000821	CcSEcCtD
Zuclopenthixol—Dyspepsia—Sibutramine—obesity	0.000103	0.00082	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Bupropion—obesity	0.000102	0.000812	CcSEcCtD
Zuclopenthixol—Decreased appetite—Sibutramine—obesity	0.000101	0.00081	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Sibutramine—obesity	0.000101	0.000804	CcSEcCtD
Zuclopenthixol—Shock—Bupropion—obesity	0.0001	0.000799	CcSEcCtD
Zuclopenthixol—Constipation—Sibutramine—obesity	9.98e-05	0.000796	CcSEcCtD
Zuclopenthixol—Pain—Sibutramine—obesity	9.98e-05	0.000796	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Bupropion—obesity	9.98e-05	0.000796	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Bupropion—obesity	9.96e-05	0.000795	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Orlistat—obesity	9.94e-05	0.000793	CcSEcCtD
Zuclopenthixol—Tachycardia—Bupropion—obesity	9.93e-05	0.000792	CcSEcCtD
Zuclopenthixol—Skin disorder—Bupropion—obesity	9.88e-05	0.000789	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Orlistat—obesity	9.86e-05	0.000787	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Bupropion—obesity	9.83e-05	0.000785	CcSEcCtD
Zuclopenthixol—Anorexia—Bupropion—obesity	9.7e-05	0.000774	CcSEcCtD
Zuclopenthixol—Flupentixol—DRD2—obesity	9.66e-05	0.0229	CrCbGaD
Zuclopenthixol—Feeling abnormal—Sibutramine—obesity	9.62e-05	0.000767	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Sibutramine—obesity	9.54e-05	0.000762	CcSEcCtD
Zuclopenthixol—Body temperature increased—Orlistat—obesity	9.53e-05	0.000761	CcSEcCtD
Zuclopenthixol—Abdominal pain—Orlistat—obesity	9.53e-05	0.000761	CcSEcCtD
Zuclopenthixol—Hypotension—Bupropion—obesity	9.51e-05	0.000759	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Topiramate—obesity	9.48e-05	0.000757	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Bupropion—obesity	9.27e-05	0.00074	CcSEcCtD
Zuclopenthixol—Body temperature increased—Sibutramine—obesity	9.22e-05	0.000736	CcSEcCtD
Zuclopenthixol—Abdominal pain—Sibutramine—obesity	9.22e-05	0.000736	CcSEcCtD
Zuclopenthixol—Insomnia—Bupropion—obesity	9.2e-05	0.000734	CcSEcCtD
Zuclopenthixol—Paraesthesia—Bupropion—obesity	9.13e-05	0.000729	CcSEcCtD
Zuclopenthixol—Clozapine—HRH3—obesity	9.13e-05	0.0216	CrCbGaD
Zuclopenthixol—Dyspnoea—Bupropion—obesity	9.07e-05	0.000724	CcSEcCtD
Zuclopenthixol—Somnolence—Bupropion—obesity	9.04e-05	0.000722	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Topiramate—obesity	9.01e-05	0.000719	CcSEcCtD
Zuclopenthixol—Oedema peripheral—Topiramate—obesity	8.99e-05	0.000717	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Topiramate—obesity	8.96e-05	0.000715	CcSEcCtD
Zuclopenthixol—Dyspepsia—Bupropion—obesity	8.95e-05	0.000715	CcSEcCtD
Zuclopenthixol—Urethral disorder—Topiramate—obesity	8.94e-05	0.000714	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Orlistat—obesity	8.88e-05	0.000709	CcSEcCtD
Zuclopenthixol—Decreased appetite—Bupropion—obesity	8.84e-05	0.000706	CcSEcCtD
Zuclopenthixol—Visual impairment—Topiramate—obesity	8.79e-05	0.000702	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Bupropion—obesity	8.78e-05	0.000701	CcSEcCtD
Zuclopenthixol—Fatigue—Bupropion—obesity	8.77e-05	0.0007	CcSEcCtD
Zuclopenthixol—Pain—Bupropion—obesity	8.7e-05	0.000694	CcSEcCtD
Zuclopenthixol—Constipation—Bupropion—obesity	8.7e-05	0.000694	CcSEcCtD
Zuclopenthixol—Asthenia—Orlistat—obesity	8.65e-05	0.00069	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Sibutramine—obesity	8.6e-05	0.000686	CcSEcCtD
Zuclopenthixol—Acetophenazine—DRD2—obesity	8.57e-05	0.0203	CrCbGaD
Zuclopenthixol—Pruritus—Orlistat—obesity	8.53e-05	0.000681	CcSEcCtD
Zuclopenthixol—Eye disorder—Topiramate—obesity	8.53e-05	0.00068	CcSEcCtD
Zuclopenthixol—Tinnitus—Topiramate—obesity	8.51e-05	0.000679	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Topiramate—obesity	8.47e-05	0.000676	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Bupropion—obesity	8.38e-05	0.000669	CcSEcCtD
Zuclopenthixol—Asthenia—Sibutramine—obesity	8.37e-05	0.000668	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Bupropion—obesity	8.32e-05	0.000664	CcSEcCtD
Zuclopenthixol—Angiopathy—Topiramate—obesity	8.28e-05	0.000661	CcSEcCtD
Zuclopenthixol—Pruritus—Sibutramine—obesity	8.26e-05	0.000659	CcSEcCtD
Zuclopenthixol—Thioproperazine—SLC22A1—obesity	8.25e-05	0.0195	CrCbGaD
Zuclopenthixol—Diarrhoea—Orlistat—obesity	8.25e-05	0.000658	CcSEcCtD
Zuclopenthixol—Immune system disorder—Topiramate—obesity	8.24e-05	0.000658	CcSEcCtD
Zuclopenthixol—Thiothixene—SLC22A1—obesity	8.12e-05	0.0192	CrCbGaD
Zuclopenthixol—Pipotiazine—SLC22A1—obesity	8.12e-05	0.0192	CrCbGaD
Zuclopenthixol—Body temperature increased—Bupropion—obesity	8.04e-05	0.000642	CcSEcCtD
Zuclopenthixol—Abdominal pain—Bupropion—obesity	8.04e-05	0.000642	CcSEcCtD
Zuclopenthixol—Mental disorder—Topiramate—obesity	7.99e-05	0.000638	CcSEcCtD
Zuclopenthixol—Diarrhoea—Sibutramine—obesity	7.98e-05	0.000637	CcSEcCtD
Zuclopenthixol—Dizziness—Orlistat—obesity	7.97e-05	0.000636	CcSEcCtD
Zuclopenthixol—Erythema—Topiramate—obesity	7.94e-05	0.000634	CcSEcCtD
Zuclopenthixol—Malnutrition—Topiramate—obesity	7.94e-05	0.000634	CcSEcCtD
Zuclopenthixol—Flatulence—Topiramate—obesity	7.83e-05	0.000625	CcSEcCtD
Zuclopenthixol—Tension—Topiramate—obesity	7.79e-05	0.000622	CcSEcCtD
Zuclopenthixol—Dizziness—Sibutramine—obesity	7.72e-05	0.000616	CcSEcCtD
Zuclopenthixol—Nervousness—Topiramate—obesity	7.71e-05	0.000616	CcSEcCtD
Zuclopenthixol—Vomiting—Orlistat—obesity	7.67e-05	0.000612	CcSEcCtD
Zuclopenthixol—Rash—Orlistat—obesity	7.6e-05	0.000607	CcSEcCtD
Zuclopenthixol—Dermatitis—Orlistat—obesity	7.6e-05	0.000606	CcSEcCtD
Zuclopenthixol—Headache—Orlistat—obesity	7.55e-05	0.000603	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Bupropion—obesity	7.49e-05	0.000598	CcSEcCtD
Zuclopenthixol—Vision blurred—Topiramate—obesity	7.48e-05	0.000597	CcSEcCtD
Zuclopenthixol—Flupentixol—HTR2A—obesity	7.46e-05	0.0177	CrCbGaD
Zuclopenthixol—Tremor—Topiramate—obesity	7.44e-05	0.000594	CcSEcCtD
Zuclopenthixol—Vomiting—Sibutramine—obesity	7.42e-05	0.000592	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Topiramate—obesity	7.37e-05	0.000588	CcSEcCtD
Zuclopenthixol—Rash—Sibutramine—obesity	7.36e-05	0.000587	CcSEcCtD
Zuclopenthixol—Dermatitis—Sibutramine—obesity	7.35e-05	0.000587	CcSEcCtD
Zuclopenthixol—Headache—Sibutramine—obesity	7.31e-05	0.000583	CcSEcCtD
Zuclopenthixol—Asthenia—Bupropion—obesity	7.3e-05	0.000583	CcSEcCtD
Zuclopenthixol—Agitation—Topiramate—obesity	7.3e-05	0.000582	CcSEcCtD
Zuclopenthixol—Pruritus—Bupropion—obesity	7.2e-05	0.000574	CcSEcCtD
Zuclopenthixol—Nausea—Orlistat—obesity	7.16e-05	0.000572	CcSEcCtD
Zuclopenthixol—Malaise—Topiramate—obesity	7.16e-05	0.000572	CcSEcCtD
Zuclopenthixol—Vertigo—Topiramate—obesity	7.13e-05	0.000569	CcSEcCtD
Zuclopenthixol—Syncope—Topiramate—obesity	7.12e-05	0.000568	CcSEcCtD
Zuclopenthixol—Leukopenia—Topiramate—obesity	7.11e-05	0.000567	CcSEcCtD
Zuclopenthixol—Palpitations—Topiramate—obesity	7.02e-05	0.00056	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Topiramate—obesity	6.98e-05	0.000557	CcSEcCtD
Zuclopenthixol—Diarrhoea—Bupropion—obesity	6.96e-05	0.000556	CcSEcCtD
Zuclopenthixol—Nausea—Sibutramine—obesity	6.93e-05	0.000553	CcSEcCtD
Zuclopenthixol—Amoxapine—DRD4—obesity	6.89e-05	0.0163	CrCbGaD
Zuclopenthixol—Convulsion—Topiramate—obesity	6.88e-05	0.000549	CcSEcCtD
Zuclopenthixol—Hypertension—Topiramate—obesity	6.86e-05	0.000547	CcSEcCtD
Zuclopenthixol—Myalgia—Topiramate—obesity	6.76e-05	0.00054	CcSEcCtD
Zuclopenthixol—Thioproperazine—DRD1—obesity	6.75e-05	0.016	CrCbGaD
Zuclopenthixol—Anxiety—Topiramate—obesity	6.74e-05	0.000538	CcSEcCtD
Zuclopenthixol—Dizziness—Bupropion—obesity	6.73e-05	0.000537	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	6.71e-05	0.000536	CcSEcCtD
Zuclopenthixol—Discomfort—Topiramate—obesity	6.68e-05	0.000533	CcSEcCtD
Zuclopenthixol—Thiothixene—DRD1—obesity	6.64e-05	0.0157	CrCbGaD
Zuclopenthixol—Pipotiazine—DRD1—obesity	6.64e-05	0.0157	CrCbGaD
Zuclopenthixol—Dry mouth—Topiramate—obesity	6.61e-05	0.000528	CcSEcCtD
Zuclopenthixol—Nefazodone—HTR2C—obesity	6.55e-05	0.0155	CrCbGaD
Zuclopenthixol—Domperidone—DRD2—obesity	6.5e-05	0.0154	CrCbGaD
Zuclopenthixol—Vomiting—Bupropion—obesity	6.47e-05	0.000516	CcSEcCtD
Zuclopenthixol—Rash—Bupropion—obesity	6.41e-05	0.000512	CcSEcCtD
Zuclopenthixol—Dermatitis—Bupropion—obesity	6.41e-05	0.000511	CcSEcCtD
Zuclopenthixol—Shock—Topiramate—obesity	6.38e-05	0.000509	CcSEcCtD
Zuclopenthixol—Headache—Bupropion—obesity	6.37e-05	0.000509	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Topiramate—obesity	6.36e-05	0.000507	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Topiramate—obesity	6.35e-05	0.000506	CcSEcCtD
Zuclopenthixol—Tachycardia—Topiramate—obesity	6.33e-05	0.000505	CcSEcCtD
Zuclopenthixol—Skin disorder—Topiramate—obesity	6.3e-05	0.000502	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Topiramate—obesity	6.27e-05	0.0005	CcSEcCtD
Zuclopenthixol—Anorexia—Topiramate—obesity	6.18e-05	0.000493	CcSEcCtD
Zuclopenthixol—Amoxapine—HTR1B—obesity	6.12e-05	0.0145	CrCbGaD
Zuclopenthixol—Trazodone—HTR2C—obesity	6.06e-05	0.0143	CrCbGaD
Zuclopenthixol—Hypotension—Topiramate—obesity	6.06e-05	0.000483	CcSEcCtD
Zuclopenthixol—Nausea—Bupropion—obesity	6.04e-05	0.000482	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Topiramate—obesity	5.9e-05	0.000471	CcSEcCtD
Zuclopenthixol—Insomnia—Topiramate—obesity	5.86e-05	0.000468	CcSEcCtD
Zuclopenthixol—Amoxapine—DRD1—obesity	5.83e-05	0.0138	CrCbGaD
Zuclopenthixol—Paraesthesia—Topiramate—obesity	5.82e-05	0.000464	CcSEcCtD
Zuclopenthixol—Dyspnoea—Topiramate—obesity	5.78e-05	0.000461	CcSEcCtD
Zuclopenthixol—Somnolence—Topiramate—obesity	5.76e-05	0.00046	CcSEcCtD
Zuclopenthixol—Fluphenazine—DRD1—obesity	5.74e-05	0.0136	CrCbGaD
Zuclopenthixol—Dyspepsia—Topiramate—obesity	5.71e-05	0.000455	CcSEcCtD
Zuclopenthixol—Thiothixene—HTR2C—obesity	5.68e-05	0.0134	CrCbGaD
Zuclopenthixol—Decreased appetite—Topiramate—obesity	5.63e-05	0.00045	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Topiramate—obesity	5.6e-05	0.000447	CcSEcCtD
Zuclopenthixol—Fatigue—Topiramate—obesity	5.59e-05	0.000446	CcSEcCtD
Zuclopenthixol—Pain—Topiramate—obesity	5.54e-05	0.000442	CcSEcCtD
Zuclopenthixol—Constipation—Topiramate—obesity	5.54e-05	0.000442	CcSEcCtD
Zuclopenthixol—Prochlorperazine—HTR2C—obesity	5.43e-05	0.0128	CrCbGaD
Zuclopenthixol—Nefazodone—SLC6A4—obesity	5.43e-05	0.0128	CrCbGaD
Zuclopenthixol—Loxapine—DRD4—obesity	5.38e-05	0.0127	CrCbGaD
Zuclopenthixol—Feeling abnormal—Topiramate—obesity	5.34e-05	0.000426	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Topiramate—obesity	5.3e-05	0.000423	CcSEcCtD
Zuclopenthixol—Quetiapine—DRD4—obesity	5.25e-05	0.0124	CrCbGaD
Zuclopenthixol—Chlorprothixene—DRD1—obesity	5.22e-05	0.0124	CrCbGaD
Zuclopenthixol—Body temperature increased—Topiramate—obesity	5.12e-05	0.000409	CcSEcCtD
Zuclopenthixol—Abdominal pain—Topiramate—obesity	5.12e-05	0.000409	CcSEcCtD
Zuclopenthixol—Trazodone—SLC6A4—obesity	5.02e-05	0.0119	CrCbGaD
Zuclopenthixol—Amoxapine—HTR2C—obesity	4.99e-05	0.0118	CrCbGaD
Zuclopenthixol—Thioridazine—DRD1—obesity	4.94e-05	0.0117	CrCbGaD
Zuclopenthixol—Fluphenazine—HTR2C—obesity	4.91e-05	0.0116	CrCbGaD
Zuclopenthixol—Loxapine—HTR1B—obesity	4.78e-05	0.0113	CrCbGaD
Zuclopenthixol—Hypersensitivity—Topiramate—obesity	4.78e-05	0.000381	CcSEcCtD
Zuclopenthixol—Thioproperazine—DRD2—obesity	4.76e-05	0.0113	CrCbGaD
Zuclopenthixol—Thiothixene—DRD2—obesity	4.68e-05	0.0111	CrCbGaD
Zuclopenthixol—Pipotiazine—DRD2—obesity	4.68e-05	0.0111	CrCbGaD
Zuclopenthixol—Quetiapine—HTR1B—obesity	4.67e-05	0.011	CrCbGaD
Zuclopenthixol—Asthenia—Topiramate—obesity	4.65e-05	0.000371	CcSEcCtD
Zuclopenthixol—Pruritus—Topiramate—obesity	4.59e-05	0.000366	CcSEcCtD
Zuclopenthixol—Loxapine—DRD1—obesity	4.56e-05	0.0108	CrCbGaD
Zuclopenthixol—Perphenazine—DRD1—obesity	4.54e-05	0.0107	CrCbGaD
Zuclopenthixol—Clozapine—DRD4—obesity	4.52e-05	0.0107	CrCbGaD
Zuclopenthixol—Prochlorperazine—DRD2—obesity	4.47e-05	0.0106	CrCbGaD
Zuclopenthixol—Chlorprothixene—HTR2C—obesity	4.47e-05	0.0106	CrCbGaD
Zuclopenthixol—Quetiapine—DRD1—obesity	4.45e-05	0.0105	CrCbGaD
Zuclopenthixol—Diarrhoea—Topiramate—obesity	4.43e-05	0.000354	CcSEcCtD
Zuclopenthixol—Chlorpromazine—SLC22A1—obesity	4.4e-05	0.0104	CrCbGaD
Zuclopenthixol—Dizziness—Topiramate—obesity	4.29e-05	0.000342	CcSEcCtD
Zuclopenthixol—Chlorpromazine—DRD4—obesity	4.25e-05	0.0101	CrCbGaD
Zuclopenthixol—Loxapine—ADRB1—obesity	4.23e-05	0.01	CrCbGaD
Zuclopenthixol—Thioridazine—HTR2C—obesity	4.23e-05	0.01	CrCbGaD
Zuclopenthixol—Nefazodone—HTR2A—obesity	4.17e-05	0.00987	CrCbGaD
Zuclopenthixol—Amoxapine—SLC6A4—obesity	4.14e-05	0.00979	CrCbGaD
Zuclopenthixol—Vomiting—Topiramate—obesity	4.12e-05	0.000329	CcSEcCtD
Zuclopenthixol—Amoxapine—DRD2—obesity	4.11e-05	0.00973	CrCbGaD
Zuclopenthixol—Rash—Topiramate—obesity	4.09e-05	0.000326	CcSEcCtD
Zuclopenthixol—Dermatitis—Topiramate—obesity	4.08e-05	0.000326	CcSEcCtD
Zuclopenthixol—Headache—Topiramate—obesity	4.06e-05	0.000324	CcSEcCtD
Zuclopenthixol—Fluphenazine—DRD2—obesity	4.04e-05	0.00957	CrCbGaD
Zuclopenthixol—Clozapine—HTR1B—obesity	4.01e-05	0.0095	CrCbGaD
Zuclopenthixol—Trifluoperazine—HTR2C—obesity	3.92e-05	0.00928	CrCbGaD
Zuclopenthixol—Loxapine—HTR2C—obesity	3.9e-05	0.00923	CrCbGaD
Zuclopenthixol—Fluphenazine—CYP2E1—obesity	3.89e-05	0.00921	CrCbGaD
Zuclopenthixol—Perphenazine—HTR2C—obesity	3.88e-05	0.00918	CrCbGaD
Zuclopenthixol—Trazodone—HTR2A—obesity	3.86e-05	0.00913	CrCbGaD
Zuclopenthixol—Nausea—Topiramate—obesity	3.85e-05	0.000307	CcSEcCtD
Zuclopenthixol—Clozapine—DRD1—obesity	3.83e-05	0.00905	CrCbGaD
Zuclopenthixol—Quetiapine—HTR2C—obesity	3.8e-05	0.009	CrCbGaD
Zuclopenthixol—Chlorprothixene—DRD2—obesity	3.68e-05	0.00871	CrCbGaD
Zuclopenthixol—Thioproperazine—HTR2A—obesity	3.67e-05	0.0087	CrCbGaD
Zuclopenthixol—Thiothixene—HTR2A—obesity	3.62e-05	0.00856	CrCbGaD
Zuclopenthixol—Pipotiazine—HTR2A—obesity	3.62e-05	0.00856	CrCbGaD
Zuclopenthixol—Chlorpromazine—DRD1—obesity	3.6e-05	0.00852	CrCbGaD
Zuclopenthixol—Thioridazine—DRD2—obesity	3.48e-05	0.00825	CrCbGaD
Zuclopenthixol—Thioridazine—CYP2E1—obesity	3.35e-05	0.00794	CrCbGaD
Zuclopenthixol—Clozapine—HTR2C—obesity	3.27e-05	0.00775	CrCbGaD
Zuclopenthixol—Chlorpromazine—BCHE—obesity	3.27e-05	0.00773	CrCbGaD
Zuclopenthixol—Trifluoperazine—DRD2—obesity	3.23e-05	0.00765	CrCbGaD
Zuclopenthixol—Loxapine—SLC6A4—obesity	3.23e-05	0.00764	CrCbGaD
Zuclopenthixol—Loxapine—DRD2—obesity	3.21e-05	0.0076	CrCbGaD
Zuclopenthixol—Perphenazine—DRD2—obesity	3.2e-05	0.00757	CrCbGaD
Zuclopenthixol—Amoxapine—HTR2A—obesity	3.18e-05	0.00752	CrCbGaD
Zuclopenthixol—Quetiapine—DRD2—obesity	3.14e-05	0.00742	CrCbGaD
Zuclopenthixol—Fluphenazine—HTR2A—obesity	3.12e-05	0.0074	CrCbGaD
Zuclopenthixol—Chlorpromazine—HTR2C—obesity	3.08e-05	0.00729	CrCbGaD
Zuclopenthixol—Chlorprothixene—HTR2A—obesity	2.85e-05	0.00673	CrCbGaD
Zuclopenthixol—Clozapine—DRD2—obesity	2.7e-05	0.00638	CrCbGaD
Zuclopenthixol—Thioridazine—HTR2A—obesity	2.69e-05	0.00637	CrCbGaD
Zuclopenthixol—Clozapine—CYP2E1—obesity	2.6e-05	0.00614	CrCbGaD
Zuclopenthixol—Chlorpromazine—DRD2—obesity	2.54e-05	0.006	CrCbGaD
Zuclopenthixol—Thioproperazine—ALB—obesity	2.51e-05	0.00595	CrCbGaD
Zuclopenthixol—Trifluoperazine—HTR2A—obesity	2.5e-05	0.00591	CrCbGaD
Zuclopenthixol—Loxapine—HTR2A—obesity	2.48e-05	0.00588	CrCbGaD
Zuclopenthixol—Thiothixene—ALB—obesity	2.47e-05	0.00586	CrCbGaD
Zuclopenthixol—Pipotiazine—ALB—obesity	2.47e-05	0.00586	CrCbGaD
Zuclopenthixol—Perphenazine—HTR2A—obesity	2.47e-05	0.00585	CrCbGaD
Zuclopenthixol—Chlorpromazine—CYP2E1—obesity	2.44e-05	0.00578	CrCbGaD
Zuclopenthixol—Quetiapine—HTR2A—obesity	2.42e-05	0.00573	CrCbGaD
Zuclopenthixol—Clozapine—HTR2A—obesity	2.08e-05	0.00493	CrCbGaD
Zuclopenthixol—Chlorpromazine—HTR2A—obesity	1.96e-05	0.00464	CrCbGaD
Zuclopenthixol—Chlorpromazine—ALB—obesity	1.34e-05	0.00317	CrCbGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IRS2—obesity	2.46e-06	2.54e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—APOE—obesity	2.46e-06	2.54e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—LEP—obesity	2.46e-06	2.54e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PRKCD—obesity	2.46e-06	2.54e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—AGT—obesity	2.46e-06	2.54e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—LEP—obesity	2.46e-06	2.53e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—APOE—obesity	2.46e-06	2.53e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CAV1—obesity	2.44e-06	2.52e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CAV1—obesity	2.43e-06	2.51e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—APOA1—obesity	2.43e-06	2.51e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL6—obesity	2.43e-06	2.51e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—APOA1—obesity	2.43e-06	2.5e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PIK3CG—obesity	2.42e-06	2.49e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—LEP—obesity	2.41e-06	2.49e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—APOE—obesity	2.41e-06	2.49e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—HTR2A—obesity	2.41e-06	2.48e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—C3—obesity	2.41e-06	2.48e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ESR1—obesity	2.39e-06	2.46e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CAV1—obesity	2.39e-06	2.46e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—APOA1—obesity	2.38e-06	2.46e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—PIK3CA—obesity	2.36e-06	2.44e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—F2—obesity	2.36e-06	2.43e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PRKCB—obesity	2.36e-06	2.43e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ESR1—obesity	2.35e-06	2.42e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ESR1—obesity	2.35e-06	2.42e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PPARG—obesity	2.33e-06	2.41e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—BAD—obesity	2.33e-06	2.4e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PRKCB—obesity	2.32e-06	2.39e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—F2—obesity	2.32e-06	2.39e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—COMT—obesity	2.32e-06	2.39e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—F2—obesity	2.32e-06	2.39e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PRKCB—obesity	2.32e-06	2.39e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MMP9—obesity	2.31e-06	2.39e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ESR1—obesity	2.3e-06	2.37e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—POMC—obesity	2.3e-06	2.37e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—BAD—obesity	2.29e-06	2.37e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PIK3CB—obesity	2.29e-06	2.36e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MTOR—obesity	2.29e-06	2.36e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—BAD—obesity	2.29e-06	2.36e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IRS2—obesity	2.29e-06	2.36e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—INS—obesity	2.29e-06	2.36e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GNB3—obesity	2.29e-06	2.36e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PPARGC1A—obesity	2.29e-06	2.36e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AGT—obesity	2.29e-06	2.36e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—HMOX1—obesity	2.28e-06	2.35e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—AKT1—obesity	2.28e-06	2.35e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—F2—obesity	2.27e-06	2.34e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PRKCB—obesity	2.27e-06	2.34e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PIK3CG—obesity	2.26e-06	2.33e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MAPK8—obesity	2.25e-06	2.32e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—BAD—obesity	2.25e-06	2.32e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—AKT1—obesity	2.24e-06	2.31e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—APOE—obesity	2.24e-06	2.31e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—LEP—obesity	2.24e-06	2.31e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IRS1—obesity	2.23e-06	2.3e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GNAS—obesity	2.23e-06	2.3e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PIK3CG—obesity	2.22e-06	2.29e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CAV1—obesity	2.22e-06	2.29e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PIK3CG—obesity	2.22e-06	2.29e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—APOA1—obesity	2.21e-06	2.28e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IRS1—obesity	2.2e-06	2.26e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IRS1—obesity	2.19e-06	2.26e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APOB—obesity	2.18e-06	2.25e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PIK3CG—obesity	2.18e-06	2.24e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IRS1—obesity	2.15e-06	2.22e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—POMC—obesity	2.15e-06	2.22e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ESR1—obesity	2.14e-06	2.21e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—INS—obesity	2.14e-06	2.2e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—AKT1—obesity	2.13e-06	2.19e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PIK3CD—obesity	2.13e-06	2.19e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—POMC—obesity	2.12e-06	2.18e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—F2—obesity	2.11e-06	2.18e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PRKCB—obesity	2.11e-06	2.18e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—POMC—obesity	2.11e-06	2.18e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—INS—obesity	2.1e-06	2.17e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCL2—obesity	2.1e-06	2.17e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—PIK3CA—obesity	2.1e-06	2.17e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—INS—obesity	2.1e-06	2.16e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ALB—obesity	2.1e-06	2.16e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL6—obesity	2.09e-06	2.16e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—BAD—obesity	2.09e-06	2.15e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—LPL—obesity	2.08e-06	2.15e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—POMC—obesity	2.07e-06	2.14e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCL2—obesity	2.07e-06	2.13e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IGF1—obesity	2.07e-06	2.13e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—AKT2—obesity	2.07e-06	2.13e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCL2—obesity	2.06e-06	2.13e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—INS—obesity	2.06e-06	2.12e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—STAT3—obesity	2.06e-06	2.12e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IGF1—obesity	2.03e-06	2.1e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—AKT2—obesity	2.03e-06	2.1e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GPX1—obesity	2.03e-06	2.1e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IGF1—obesity	2.03e-06	2.09e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—AKT2—obesity	2.03e-06	2.09e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCL2—obesity	2.03e-06	2.09e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PIK3CG—obesity	2.02e-06	2.08e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PIK3R1—obesity	2.01e-06	2.07e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—NOS3—obesity	2.01e-06	2.07e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IRS1—obesity	2e-06	2.06e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IGF1—obesity	1.99e-06	2.05e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MMP9—obesity	1.99e-06	2.05e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—AKT2—obesity	1.99e-06	2.05e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PIK3CD—obesity	1.99e-06	2.05e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CD36—obesity	1.98e-06	2.04e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—PIK3CA—obesity	1.97e-06	2.03e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SERPINE1—obesity	1.96e-06	2.02e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PIK3CD—obesity	1.95e-06	2.01e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PIK3CD—obesity	1.95e-06	2.01e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MAPK8—obesity	1.94e-06	2e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—PIK3CA—obesity	1.93e-06	2e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—AKT1—obesity	1.93e-06	1.99e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SERPINE1—obesity	1.93e-06	1.99e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—PIK3CA—obesity	1.93e-06	1.99e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SERPINE1—obesity	1.93e-06	1.99e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—POMC—obesity	1.92e-06	1.98e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—INS—obesity	1.91e-06	1.97e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PIK3CD—obesity	1.91e-06	1.97e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MYC—obesity	1.91e-06	1.97e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TYK2—obesity	1.91e-06	1.97e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TGFB1—obesity	1.91e-06	1.97e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	1.89e-06	1.95e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—RHOA—obesity	1.89e-06	1.95e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SERPINE1—obesity	1.89e-06	1.95e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCL2—obesity	1.88e-06	1.94e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TYK2—obesity	1.88e-06	1.94e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TYK2—obesity	1.88e-06	1.93e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—MTHFR—obesity	1.87e-06	1.93e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NOS3—obesity	1.87e-06	1.93e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PIK3R1—obesity	1.87e-06	1.93e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—RHOA—obesity	1.86e-06	1.92e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL6—obesity	1.86e-06	1.92e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—RHOA—obesity	1.86e-06	1.92e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PIK3CB—obesity	1.85e-06	1.91e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IGF1—obesity	1.85e-06	1.91e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AKT2—obesity	1.85e-06	1.91e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PIK3R1—obesity	1.84e-06	1.9e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NOS3—obesity	1.84e-06	1.9e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PIK3R1—obesity	1.84e-06	1.9e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NOS3—obesity	1.84e-06	1.9e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TYK2—obesity	1.84e-06	1.9e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PPARA—obesity	1.84e-06	1.9e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PTGS2—obesity	1.84e-06	1.89e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—RHOA—obesity	1.82e-06	1.88e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NOS3—obesity	1.81e-06	1.86e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PIK3R1—obesity	1.81e-06	1.86e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—PIK3CA—obesity	1.79e-06	1.84e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—AGT—obesity	1.78e-06	1.84e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PIK3CD—obesity	1.78e-06	1.83e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—STAT3—obesity	1.77e-06	1.83e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	1.76e-06	1.82e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SERPINE1—obesity	1.76e-06	1.81e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—PIK3CA—obesity	1.76e-06	1.81e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—PIK3CA—obesity	1.75e-06	1.81e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APOE—obesity	1.75e-06	1.8e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MTOR—obesity	1.73e-06	1.78e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PIK3CB—obesity	1.73e-06	1.78e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CAV1—obesity	1.73e-06	1.78e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APOA1—obesity	1.73e-06	1.78e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—PIK3CA—obesity	1.72e-06	1.77e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—AKT1—obesity	1.72e-06	1.77e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TYK2—obesity	1.71e-06	1.76e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MTOR—obesity	1.7e-06	1.76e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PIK3CB—obesity	1.7e-06	1.76e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MTOR—obesity	1.7e-06	1.75e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PIK3CB—obesity	1.7e-06	1.75e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—RHOA—obesity	1.7e-06	1.75e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NOS3—obesity	1.68e-06	1.73e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PIK3R1—obesity	1.68e-06	1.73e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MTOR—obesity	1.67e-06	1.72e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PIK3CB—obesity	1.67e-06	1.72e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MYC—obesity	1.65e-06	1.7e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TGFB1—obesity	1.64e-06	1.69e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—PIK3CA—obesity	1.62e-06	1.67e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—AKT1—obesity	1.61e-06	1.66e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—PIK3CA—obesity	1.6e-06	1.65e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL6—obesity	1.58e-06	1.63e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—AKT1—obesity	1.58e-06	1.63e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—AKT1—obesity	1.58e-06	1.63e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PIK3CG—obesity	1.58e-06	1.62e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL6—obesity	1.56e-06	1.6e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL6—obesity	1.55e-06	1.6e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MTOR—obesity	1.55e-06	1.6e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PIK3CB—obesity	1.55e-06	1.6e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—AKT1—obesity	1.55e-06	1.6e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL6—obesity	1.52e-06	1.57e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PPARG—obesity	1.52e-06	1.57e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MMP9—obesity	1.5e-06	1.55e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—POMC—obesity	1.5e-06	1.55e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—INS—obesity	1.49e-06	1.54e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MMP9—obesity	1.48e-06	1.53e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MMP9—obesity	1.48e-06	1.52e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MAPK8—obesity	1.46e-06	1.51e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—AKT1—obesity	1.46e-06	1.5e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MMP9—obesity	1.45e-06	1.49e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MAPK8—obesity	1.44e-06	1.48e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—AKT1—obesity	1.44e-06	1.48e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL6—obesity	1.44e-06	1.48e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MAPK8—obesity	1.44e-06	1.48e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—AKT1—obesity	1.44e-06	1.48e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—AKT1—obesity	1.43e-06	1.48e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL6—obesity	1.42e-06	1.46e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MAPK8—obesity	1.41e-06	1.45e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—AKT1—obesity	1.41e-06	1.45e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PIK3CA—obesity	1.4e-06	1.44e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PIK3CD—obesity	1.38e-06	1.43e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ALB—obesity	1.37e-06	1.41e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MMP9—obesity	1.35e-06	1.39e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—STAT3—obesity	1.34e-06	1.38e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—AKT1—obesity	1.33e-06	1.37e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—STAT3—obesity	1.32e-06	1.36e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—STAT3—obesity	1.31e-06	1.35e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MAPK8—obesity	1.31e-06	1.35e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PIK3R1—obesity	1.31e-06	1.35e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—NOS3—obesity	1.31e-06	1.35e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—AKT1—obesity	1.31e-06	1.35e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—STAT3—obesity	1.29e-06	1.33e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MYC—obesity	1.24e-06	1.28e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TGFB1—obesity	1.24e-06	1.28e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL6—obesity	1.24e-06	1.28e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MYC—obesity	1.22e-06	1.26e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MYC—obesity	1.22e-06	1.26e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TGFB1—obesity	1.22e-06	1.26e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TGFB1—obesity	1.22e-06	1.26e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PIK3CB—obesity	1.21e-06	1.24e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MYC—obesity	1.2e-06	1.23e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—STAT3—obesity	1.2e-06	1.23e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PTGS2—obesity	1.2e-06	1.23e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TGFB1—obesity	1.19e-06	1.23e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—AKT1—obesity	1.14e-06	1.18e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PIK3CA—obesity	1.13e-06	1.16e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MYC—obesity	1.11e-06	1.15e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TGFB1—obesity	1.11e-06	1.14e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PIK3CA—obesity	1.05e-06	1.09e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PIK3CA—obesity	1.04e-06	1.07e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PIK3CA—obesity	1.04e-06	1.07e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PIK3CA—obesity	1.02e-06	1.05e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PIK3CA—obesity	9.44e-07	9.74e-06	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6—obesity	9.34e-07	9.63e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—AKT1—obesity	9.22e-07	9.51e-06	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6—obesity	9.19e-07	9.48e-06	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6—obesity	9.17e-07	9.46e-06	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6—obesity	9e-07	9.28e-06	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—AKT1—obesity	8.62e-07	8.89e-06	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—AKT1—obesity	8.48e-07	8.74e-06	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—AKT1—obesity	8.46e-07	8.72e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6—obesity	8.36e-07	8.62e-06	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—AKT1—obesity	8.3e-07	8.56e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AKT1—obesity	7.71e-07	7.95e-06	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PIK3CA—obesity	7.36e-07	7.59e-06	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—AKT1—obesity	6.01e-07	6.2e-06	CbGpPWpGaD
